5-Hydroxylansoprazole
Modify Date: 2025-08-21 18:44:11
5-Hydroxylansoprazole structure
|
Common Name | 5-Hydroxylansoprazole | ||
|---|---|---|---|---|
| CAS Number | 131926-98-2 | Molecular Weight | 385.36100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H14F3N3O3S | Melting Point | >155ºC (dec.) | |
| MSDS | N/A | Flash Point | N/A | |
Use of 5-Hydroxylansoprazole5-Hydroxylansoprazole (AG1908) is an active metabolite of Lansoprazole in plasma. Lansoprazole is metabolized by CYP2C19 forming 5-Hydroxylansoprazole. Lansoprazole is a gastric proton-pump inhibitor and is effective in the treatment of various peptic diseases[1][2]. |
| Name | 5-hydroxy lansoprazole |
|---|---|
| Synonym | More Synonyms |
| Description | 5-Hydroxylansoprazole (AG1908) is an active metabolite of Lansoprazole in plasma. Lansoprazole is metabolized by CYP2C19 forming 5-Hydroxylansoprazole. Lansoprazole is a gastric proton-pump inhibitor and is effective in the treatment of various peptic diseases[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Proton Pump[1] |
| References |
| Melting Point | >155ºC (dec.) |
|---|---|
| Molecular Formula | C16H14F3N3O3S |
| Molecular Weight | 385.36100 |
| Exact Mass | 385.07100 |
| PSA | 107.31000 |
| LogP | 4.08650 |
| 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-5-ol |
| 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfinyl]-5-hydroxy-1H-benzimidazole |
| AG-1908 |
| 2-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole-5-ol |
| 5'-hydroxylansoprazole |
| Lansoprazole Impurity 18 |